.webp)
67/100B67.290
USD
-0.26
(-0.38%)
Post Trading·68.800USD+1.510(+2.24%)
Last updated: · Delayed 15 min
Fair value63.11Plus+7%48Price 67.2994
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Who owns Royalty Pharma?What is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
Institutions own 83.2% of Royalty Pharma's shares, through 660 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were Morgan Stanley (9.6%), Capital International Investors (7.9%), BlackRock, Inc. (6.3%).
- Institutions ownWhat is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
- 83.2%
- Institutional holders
- 660
- The 10 largest hold
- 43.3%
- Free floatWhat is free float? Free float is the part of a company's shares that anyone can buy and sell: all its shares minus those held by insiders, founders and owners of over 5%.
- 94.0%
- Holdings as of
- 30 Jun 2026
Who owns the shares
10 largest holders 43.3% Other institutions 39.9% Individuals and others 16.8%
Shares free to trade
Free float 418.41M shares ·94.0% Closely held 26.86M shares ·6.0%
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
The largest shareholders
| # | Holder | Shares | Of the company | Value | Change last quarter (shares) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 42,931,597 | 9.65% | 2.41B USD | -640,036 |
| 2 | Capital International Investors | 35,273,770 | 7.93% | 1.98B USD | +268,034 |
| 3 | BlackRock, Inc. | 27,832,977 | 6.25% | 1.56B USD | +1,925,232 |
| 4 | FMR LLC | 24,513,814 | 5.51% | 1.37B USD | -638,428 |
| 5 | State Street Corp | 12,338,229 | 2.86% | 691.80M USD | +1,348,378 |
| 6 | Price T Rowe Associates Inc | 11,193,657 | 2.52% | 627.63M USD | +9,259,396 |
| 7 | Swedbank Ab | 10,726,608 | 2.41% | 601.44M USD | -860,085 |
| 8 | Baillie Gifford & Co | 10,015,578 | 2.25% | 561.57M USD | -6,140,099 |
| 9 | Capital World Investors | 9,517,337 | 2.14% | 533.64M USD | +1,480,623 |
| 10 | Geode Capital Management, LLC | 8,058,048 | 1.81% | 450.58M USD | +188,416 |
| 11 | Caledonia (private) Investments Pty Ltd | 5,775,851 | 1.30% | 323.85M USD | -1,392,548 |
| 12 | Norges Bank | 5,336,084 | 1.20% | 299.19M USD | New position |
| 13 | Vanguard Capital Management LLC | 4,826,617 | 1.08% | 270.63M USD | +294,731 |
| 14 | Northern Trust Corp | 4,718,859 | 1.06% | 264.59M USD | +910,124 |
| 15 | Royal London Asset Management Ltd | 4,319,595 | 0.97% | 242.20M USD | +511,242 |
| 16 | Aqr Capital Management LLC | 4,305,412 | 0.97% | 241.40M USD | +523,374 |
| 17 | Invesco Ltd. | 4,232,577 | 0.95% | 237.32M USD | +480,178 |
| 18 | Bank Of America Corp | 4,149,422 | 0.93% | 232.66M USD | +653,576 |
| 19 | Legal & General Group PLC | 3,800,504 | 0.85% | 213.09M USD | +437,632 |
| 20 | Amundi | 3,723,864 | 0.84% | 208.80M USD | +635,091 |
| 21 | Victory Capital Management Inc | 3,682,932 | 0.83% | 206.50M USD | -170,876 |
| 22 | Patient Capital Management, LLC | 3,598,808 | 0.81% | 201.79M USD | -44,908 |
| 23 | UBS Group AG | 3,143,347 | 0.71% | 176.25M USD | +1,331,144 |
| 24 | Charles Schwab Investment Management Inc | 3,083,528 | 0.69% | 172.89M USD | +55,629 |
| 25 | Sixth Street Partners Management Company, L.P. | 3,083,528 | 0.69% | 172.89M USD | New position |
All institutions last quarter
- Bought or added
- 516 · 109 new
- Sold or cut
- 228 · 52 sold out
- Net shares bought
- +12.28M · 688.53M USD
- Institutional ownership
- 82.9% → 83.2%
Biggest buyers last quarter
- Price T Rowe Associates Inc+9,259,396
- Norges BankNew position
- Sixth Street Partners Management Company, L.P.New position
- BlackRock, Inc.+1,925,232
- Nordea Investment Management Ab+1,788,750
Biggest sellers last quarter
- Baillie Gifford & Co-6,140,099
- Adage Capital Partners Gp, L.l.c.-4,980,633
- Caledonia (private) Investments Pty Ltd-1,392,548
- Citadel Advisors LLC-1,326,429
- Swedbank Ab-860,085
From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.
Common questions about Royalty Pharma's shareholders
Source: Financial Modeling Prep